|
Market Closed -
Nasdaq
00:00:00 08/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 413.08 USD | +2.60% |
|
-2.00% | +26.20% |
| 10-08 | Nasdaq Composite, S&P 500 Fall From Record Following Fed Meeting Minutes | MT |
| 10-07 | Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule | MT |
| Market Cap | 223B 200B 186B 169B 318B 21,603B 321B 2,237B 874B 10,987B 838B 820B 35,320B | P/E 2026 * |
26.1x | P/E 2027 * | 23.4x |
|---|---|---|---|---|---|
| Enterprise Value | 265B 237B 221B 201B 378B 25,617B 380B 2,653B 1,036B 13,028B 994B 973B 41,882B | EV / Sales 2026 * |
6.8x | EV / Sales 2027 * | 6.42x |
| Free-Float |
99.77% | Yield 2026 * |
2.44% | Yield 2027 * | 2.58% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
Mexican S.E.
| AMGN * | End-of-day quote | |
Boerse Muenchen
| AMG | Real-time | |
Xetra
| AMG | Delayed | |
Tradegate
| AMG | Real-time | |
London S.E.
| 0R0T | Delayed | |
CBOE
| Real-time | ||
Deutsche Boerse AG
| AMG | Delayed | |
Wiener Boerse
| AMGN | End-of-day quote | |
Börse Stuttgart
| AMG | Delayed | |
Berne S.E.
| 000907582 | End-of-day quote | |
Borsa Italiana
| 1AMGN | End-of-day quote | |
Santiago S.E.
| AMGN | End-of-day quote | |
Santiago S.E.
| AMGNCL | End-of-day quote | |
CBOE
| 0R0T | Real-time |
Last Transcript: Amgen Inc.
| 1 day | +2.60% | ||
| 1 week | -2.00% | ||
| Current month | -2.00% | ||
| 1 month | -5.52% | ||
| 3 months | +12.22% | ||
| 6 months | +21.49% | ||
| Current year | +26.20% |
| 1 week | 396.01 | 415.79 | |
| 1 month | 374.46 | 426.59 | |
| Current year | 318.21 | 447.03 | |
| 1 year | 288 | 447.03 | |
| 3 years | 249.7 | 447.03 | |
| 5 years | 198.64 | 447.03 | |
| 10 years | 133.64 | 447.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
| Director of Finance/CFO | 62 | 13/05/2010 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 65 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/09/26 | Other | Chief Financial Officer | 34,061 | 0.0063% | ||
| 13/08/26 | Exercice | Executive/Senior Manager | 3,756 | 0.0007% | ||
| 07/08/26 | Free | Director | 85 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.60% | -2.00% | +39.77% | +54.44% | 218B | ||
| +2.70% | +2.73% | +40.91% | +110.31% | 1,032B | ||
| +1.44% | -2.38% | +36.83% | +63.95% | 614B | ||
| +1.75% | +3.73% | +16.55% | +83.05% | 471B | ||
| +0.60% | -1.73% | +62.98% | +37.46% | 350B | ||
| +2.92% | +3.12% | +24.78% | +45.10% | 337B | ||
| +2.42% | +0.05% | +14.13% | +35.80% | 268B | ||
| +1.86% | -0.81% | -4.69% | +12.20% | 246B | ||
| +1.82% | -1.48% | +25.75% | +96.48% | 179B | ||
| +3.40% | +0.28% | -32.42% | -60.33% | 164B | ||
| Average | +1.65% | -1.29% | +22.46% | +47.85% | 387.85B | |
| Weighted average by Cap. | +0.92% | -0.56% | +29.29% | +65.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.94B 34.79B 32.46B 29.48B 55.53B 3,767B 55.94B 390B 152B 1,916B 146B 143B 6,158B | 40.34B 36.04B 33.63B 30.54B 57.52B 3,902B 57.95B 404B 158B 1,985B 151B 148B 6,380B |
| Net income | 8.58B 7.67B 7.15B 6.5B 12.24B 830B 12.33B 85.95B 33.58B 422B 32.21B 31.52B 1,357B | 9.39B 8.39B 7.83B 7.11B 13.39B 909B 13.49B 94.09B 36.76B 462B 35.26B 34.5B 1,486B |
| Net Debt | 41.5B 37.08B 34.59B 31.42B 59.17B 4,014B 59.62B 416B 162B 2,041B 156B 152B 6,563B | 35.77B 31.96B 29.82B 27.09B 51.02B 3,461B 51.4B 358B 140B 1,760B 134B 131B 5,658B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/10/26 | $413.08 | +2.60% | 2,236,602 |
| 06/10/26 | $402.60 | -0.09% | 2,036,870 |
| 05/10/26 | $402.98 | -0.01% | 3,104,125 |
| 02/10/26 | $403.04 | -1.04% | 3,510,312 |
| 01/10/26 | $407.27 | -3.38% | 2,501,030 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions


















